By way of derogation from Article 106(1) of this Regulation, and in the absence of a veterinary medicinal product as referred to in Article 116 of this Regulation, in the event of an outbreak of a listed disease as referred to in Article 5 of Regulation (EU) 2016/429 or an emerging disease as referred to in Article 6 of that Regulation, a competent authority may allow the use of an immunological veterinary medicinal product not authorised within the Union.
De mhaolú ar Airteagal 106(1) den Rialachán seo, agus in éagmais táirge íocshláinte tréidliachta dá dtagraítear in Airteagal 116 den Rialachán seo, i gcás ráig de ghalar liostaithe dá dtagraítear in Airteagal 5 de Rialachán (AE) 2016/429 nó de ghalar atá ag teacht chun cinn dá dtagraítear in Airteagal 6 den Rialachán sin, féadfaidh údarás inniúil cead a thabhairt go n-úsáidfí táirge íocshláinte tréidliachta imdhíoneolaíoch nach bhfuil údaraithe laistigh den Aontas.